NUVB
The table below shows Nuvation Bio Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $164.09M | $35.72M | $42.65M | $101.10M | $132.42M | $908.11K |
| Short-term investments | $365.13M | $466.97M | $568.56M | $559.91M | $632.97M | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $11.41M | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $571.52M |
| $526.25M |
| $616.43M |
| $667.32M |
| $772.07M |
| $1.25M |
| Property, plant & equipment | $564.00K | $586.00K | $717.00K | $894.00K | $786.00K | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $594.82M | $540.63M | $621.48M | $672.14M | $776.15M | $145.00M |
| Accounts payable | $9.48M | $6.35M | $2.21M | $2.14M | $3.92M | - |
| Total current liabilities | $82.23M | $58.24M | $13.97M | $13.16M | $16.93M | $2.80M |
| Long-term debt | $47.21M | - | - | - | - | - |
| Total liabilities | $289.11M | $76.84M | $16.36M | $17.07M | $30.15M | $2.80M |
| Retained earnings | -$1.12B | -$910.74M | -$342.80M | -$267.00M | -$162.80M | -$3.05M |
| Total equity | $305.72M | $463.79M | $605.12M | $655.08M | $746.00M | $5.00M |